A curated selection of analytical frameworks, due diligence models, and strategic criteria used by family offices to evaluate high-risk, high-reward deep technology startups. This list covers essential metrics ranging from scientific validation to commercialization pathways, helping investors navigate the complexities of biotech, quantum computing, and advanced materials.
Get targeted exposure with custom position pinning and highlighted placement.
Evaluates the robustness of underlying technology and the defensibility of intellectual property. This framework focuses on patent landscapes, freedom-to-operate analysis, and the uniqueness of the core scientific breakthrough to ensure long-term competitive advantage.
Adapts the traditional Technology Readiness Level model for investment purposes, specifically gauging the gap between laboratory proof-of-concept and scalable manufacturing. It assesses engineering challenges, supply chain viability, and production scalability for deep tech ventures.
Critical for healthcare, aerospace, and energy deep tech, this criterion analyzes the regulatory landscape and time-to-approval. It evaluates the clarity of FDA, FAA, or EPA pathways and the capital required to navigate complex compliance milestones.
Assesses the balance between deep scientific expertise and operational business acumen. Investors look for founding teams with proven PhD-level research capabilities paired with executives who have experience in scaling hardware or biotech companies.
Deep tech often requires significant upfront R&D capital. This criterion examines the efficiency of capital deployment, projecting burn rates against key technical milestones to ensure sufficient runway for product development without excessive dilution.
Analyzes whether the deep tech solution can unlock entirely new markets or significantly disrupt existing ones. It focuses on the scalability of the technology beyond niche applications and its potential to become a foundational platform for other innovations.
Evaluates strategic alliances with major industry players, universities, or government labs. Strong partnerships can accelerate validation, provide early revenue streams, and de-risk the commercialization process through shared resources and expertise.
Since deep tech investments often have longer horizons, this criterion assesses potential exit strategies such as strategic acquisition by large incumbents or specialized IPOs. It aligns the investment timeline with the family office’s liquidity requirements.
Many family offices prioritize investments that align with their values. This framework evaluates the environmental, social, and governance implications of the technology, particularly in areas like climate tech, sustainable materials, and responsible AI.
Moves beyond technical feasibility to verify market demand through early pilot programs and letters of intent. It assesses the willingness of enterprise customers to pay for the solution and the clarity of the value proposition in real-world scenarios.
For hardware and materials deep tech, this criterion examines the security and cost stability of the supply chain. It evaluates dependencies on single-source suppliers, geopolitical risks, and the scalability of raw material acquisition.
Analyzes direct and indirect competitors, including academic labs and multinational corporations. It assesses the startup’s ability to differentiate its technology and capture market share against entrenched players or emerging disruptive alternatives.
Evaluates the company’s ability to secure SBIR, STTR, or other government grants. This reduces equity dilution and validates the technology’s national importance, providing a significant advantage for family office investors seeking capital efficiency.
Essential for AI, quantum, and IoT deep tech, this criterion reviews the robustness of data protection measures. It assesses vulnerabilities in the technology stack and the potential for cyber threats to undermine the core business model or customer trust.
Examines the likelihood of acquisition by strategic buyers such as Big Pharma, major tech firms, or industrial conglomerates. It identifies potential acquirers and assesses the strategic fit of the deep tech startup within larger corporate portfolios.
Reviews the strategy for maintaining and enforcing patents over the long term. It evaluates the cost and process of IP maintenance, international patent filings, and the potential for licensing revenue as an alternative exit path.
Assesses the transition from prototype to mass production. It looks for evidence of modular design, standardized processes, and partnerships with contract manufacturers capable of handling large-scale production without compromising quality or margins.
A specialized metric that adjusts expected returns for the high failure rate of deep tech ventures. It incorporates probability-weighted outcomes based on technical milestones, regulatory approvals, and market adoption rates to calculate realistic IRR projections.